The emerging treatment of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide991268.get-blogging.com/42511872/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment